These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 548209

  • 1. Lecithin in the treatment of tardive dyskinesia.
    Branchey MH, Branchey LB, Bark NM, Richardson MA.
    Commun Psychopharmacol; 1979; 3(5):303-7. PubMed ID: 548209
    [No Abstract] [Full Text] [Related]

  • 2. A crossover study of lecithin treatment of tardive dyskinesia.
    Gelenberg AJ, Dorer DJ, Wojcik JD, Falk WE, Brotman AW, Leahy L.
    J Clin Psychiatry; 1990 Apr; 51(4):149-53. PubMed ID: 2182613
    [Abstract] [Full Text] [Related]

  • 3. Double-blind study of lecithin in the treatment of persistent tardive dyskinesia.
    Pérez-Cruet J, Menéndez I, Alvarez-Ghersi J, Falcón JR, Valderrábano O, Castro-Urrutia EC, Ifarraguerri C, Pérez LL.
    Bol Asoc Med P R; 1981 Nov; 73(11):531-7. PubMed ID: 6121562
    [No Abstract] [Full Text] [Related]

  • 4. Lecithin administration in tardive dyskinesia: clinical and biomedical correlates.
    Jackson IV, Davis LG, Cohen RK, Nuttall EA.
    Biol Psychiatry; 1981 Jan; 16(1):85-90. PubMed ID: 7225479
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of tardive dyskinesia with lecithin.
    Jackson IV, Nuttall EA, Ibe IO, Perez-Cruet J.
    Am J Psychiatry; 1979 Nov; 136(11):1458-60. PubMed ID: 40440
    [Abstract] [Full Text] [Related]

  • 6. Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
    Hanus H, Tůtma I, Zapletálek M, Fusek J, Hrdina V.
    Homeost Health Dis; 1991 Nov; 33(5-6):301-4. PubMed ID: 18265509
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Choline and lecithin for the treatment of tardive dyskinesia [proceedings].
    Gelenberg AJ.
    Psychopharmacol Bull; 1979 Apr; 15(2):74-5. PubMed ID: 432384
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lithium and lecithin in tardive dyskinesia: an update.
    Volavka J, O'Donnell J, Muragali R, Anderson BG, Gaztanaga P, Boggiano W, Whittaker R, Sta Maria T.
    Psychiatry Res; 1986 Oct; 19(2):101-4. PubMed ID: 3538109
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of choline and lecithin in the treatment of tardive dyskinesia.
    Zeisel SH, Gelenberg AJ, Growdon JH, Wurtman RJ.
    Adv Biochem Psychopharmacol; 1980 Oct; 24():463-70. PubMed ID: 6996444
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tardive dystonia and ceruletide effects: case report.
    Sugawara M, Iizuka H, Kawana A, Suzuki J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):127-34. PubMed ID: 1557504
    [Abstract] [Full Text] [Related]

  • 20. High-dose diazepam in neuroleptic-resistant schizophrenia with tardive dyskinesia.
    Eapen V, Mukherjee D, Chandra P, Sinha V, Khanna S, Channabasavanna SM.
    J Clin Psychiatry; 1989 Aug; 50(8):309. PubMed ID: 2569459
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.